filings.toolsItem 16. Form 10-K Summary
5K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
LENNOX INTERNATIONAL INC.
By: /s/ Alok Maskara
Alok Maskara
Chief Executive Officer
February 17, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.
| SIGNATURE | TITLE | DATE | |||||||||
| /s/ Alok Maskara | Chief Executive Officer and Director | February 17, 2026 | |||||||||
| Alok Maskara | (Principal Executive Officer) | ||||||||||
| /s/ Michael P. Quenzer | Executive Vice President and Chief Financial Officer | February 17, 2026 | |||||||||
| Michael P. Quenzer | (Principal Financial Officer) | ||||||||||
| /s/ Chris A. Kosel | Vice President, Controller and Chief Accounting Officer | February 17, 2026 | |||||||||
| Chris A. Kosel | (Principal Accounting Officer) | ||||||||||
| /s/ Todd J. Teske | Chairman of the Board of Directors | February 17, 2026 | |||||||||
| Todd J. Teske | |||||||||||
| /s/ Sherry L. Buck | Director | February 17, 2026 | |||||||||
| Sherry L. Buck | |||||||||||
| /s/ Tracy A. Embree | Director | February 17, 2026 | |||||||||
| Tracy A. Embree | |||||||||||
| /s/ John W. Norris, III | Director | February 17, 2026 | |||||||||
| John W. Norris, III | |||||||||||
| /s/ Karen H. Quintos | Director | February 17, 2026 | |||||||||
| Karen H. Quintos | |||||||||||
| /s/ Sivasankaran Somasundaram | Director | February 17, 2026 | |||||||||
| Sivasankaran Somasundaram | |||||||||||
| /s/ Jon Vander Ark | Director | February 17, 2026 | |||||||||
| Jon Vander Ark | |||||||||||
| /s/ Shane D. Wall | Director | February 17, 2026 | |||||||||
| Shane D. Wall | |||||||||||
LENNOX INTERNATIONAL INC.
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
For the Years Ended December 31, 2025, 2024 and 2023
(In millions)
| Balance at beginning of year | Additions charged to cost and expenses | Write-offs | Recoveries | Other**(1)** | Balance at end of year | ||||||||||||||||||||||||||||||
| 2023 | |||||||||||||||||||||||||||||||||||
| Allowance for doubtful accounts | $ | 15.5 | $ | 9.8 | $ | (0.2) | $ | — | $ | (10.7) | $ | 14.4 | |||||||||||||||||||||||
| 2024 | |||||||||||||||||||||||||||||||||||
| Allowance for doubtful accounts | $ | 14.4 | $ | 8.0 | $ | (0.6) | $ | — | $ | (4.0) | $ | 17.8 | |||||||||||||||||||||||
| 2025 | |||||||||||||||||||||||||||||||||||
| Allowance for doubtful accounts | $ | 17.8 | $ | 1.2 | $ | (8.5) | $ | — | $ | (2.0) | $ | 8.5 | |||||||||||||||||||||||
| (1) 2023 consists of the sale of our European businesses and other miscellaneous items. |
Previous: Item 15. Exhibits and Financial Statement Schedules